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Washington Univer si ty  in  St .  Louis  
Kurt Thoroughman, PhD, is a biomedi-
cal engineer interested in how our brains 
allow us to plan, control and learn move-
ments. Although he has worked with 
healthy human subjects before, he and 
Jennifer Semrau, a graduate student in 
neuroscience, wanted to study movement 
impairment in Parkinson's patients.  
To get the kind of advice and support 
they needed for this new research direc-
tion, they approached Joel Perlmutter, 
MD, who heads the ICTS Brain, Behavior 
and Performance Unit (BBPU).  
Perlmutter says, "Our unit not only sup-
ports neuroscience research, but pro-
motes collaborative translational re-
search, making it unique in the country." 
Some evidence suggests that Parkin-
son's disease damages parts of the brain 
that use sensory cues to learn new move-
ments. Thoroughman and Semrau de-
signed an experiment in which Parkin-
son's patients train on a tablet computer 
to move a stylus pen from one point to 
another. Then the device begins "tricking" 
them by giving odd visual cues. The re-
searchers want to know how the patients 
learn to adapt their movements to such 
cues. 
"Our goal is a better understanding of 
adaptive sensory and motor processing in 
people with Parkinson's," Thoroughman 
says. "This will allow us to refine and ad-
vance therapeutic techniques and reha-
bilitation strategies." 
With the assistance of the ICTS, 
Perlmutter provided a research coordina-
tor who helped the researchers put to-
gether a protocol. Then the BBPU helped 
recruit subjects with the aid of an exten-
sive patient database. 
Now patients participating in the study are 
being scheduled through the BBPU, a familiar 
place where they have come for previous 
clinical appointments. The BBPU staff moni-
tor the patients to ensure their health during 
the experiment.  
"Our interaction with the BBPU was instru-
mental in starting and conducting this pro-
ject," Thoroughman says. "They had a great 
deal of communication and funding re-
sources and a clinical history in running stud-
ies with Parkinson's patients." 
The BBPU also helped Thomas Thach, MD, 
professor of anatomy and neurobiology, start 
up a new clinical and translational project to 
assess the use of botulinum toxin (brand 
name Botox) for treating dystonia involving 
the hand.  
Otherwise known as writer's cramp, typist's 
cramp or pianist's cramp, the disorder 
causes the hand muscles to tighten involun-
tarily. Thach wanted to find out if botulinum 
toxin could selectively affect the stretch sen-
sors in muscle and reduce the muscle tight-
ness of dystonia. Working with Perlmutter 
and BBPU staff members, Thach is now re-
cruiting patients for the study. 
The BBPU is a 14,000 square-foot, self-
contained facility with 18 examination rooms; 
laboratory facilities, including a clean lab; a 
social work interview room; and a model 
kitchen and bathroom set up to evaluate pa-
tients' abilities to perform daily activities. The 
staff can test muscle strength and measure 
movement, including gait, and they can con-
duct structured psychiatric interviews, neu-
rologic assessments and kinematic measure-
ment.  For more information about the BBPU 
contact Johanna Hartlein at 
Johanna@wustl.edu or 314-362-0420. 
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ICTS Cores for research advancing medical knowledge that can 
improve human health.   A Letter of Support from the Director of 
the ICTS Core that will provide the requested service(s) is an 
essential part of the application and must corroborate the ser-
vice(s) to be provided and the scientific relevance of the re-
search.  Applicants may request up to $10,000 for up to 1 year 
for use of ICTS Core services.  Applications will be accepted on a 
monthly basis with an initial due date of December 10, 2008.  
The ICTS expects to make available approximately $100,000 for 
this program annually. 
 
Deadlines, complete instructions and application forms for both 
of these programs are now available on the ICTS website 
(http://www.icts.wustl.edu/funding/). 
The ICTS announces two additional funding opportunities to comple-
ment the BJHF/ICTS Clinical & Translational Research Funding Pro-
gram. 
 
Bander Business Ethics in Medical Research Funding Program 
The intent of this program is to promote innovative research that ex-
amines an ethical issue arising from the business or financial dimen-
sion of medical research, especially insofar as this dimension affects 
the quality of research or the well-being of patients enrolled in clinical 
trials.  Anticipated awards will range from $10,000 and $20,000 for 1 
year.  One or 2 proposals will be funded in 2008. 
 
Just-In-Time (JIT) Core Usage Funding Program 
This program is intended to provide quick access to funding to use the 
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Dr. Ezekiel Emanuel makes 
a point during his lecture. 
Dr. Emanuel, Alison Ebers (CRTC Staff) and 
Becky Evans (ICTS Business Director) share a 
lighter moment. Refreshments were enjoyed by all. 
Dr. Emanuel, Dr. Steven Bander, Dr. Kenneth Polonsky,                      
and Dr. James DuBois 
Dr. Bradley Evanoff and  
Dr. Victoria Fraser  
Dr. DuBois and Dr. Emanuel 
ICTS News  
―Health Care Band-Aids: How to Fix America’s 
Ailing Health Care System‖ was the topic of the 
ICTS Bander Program in Business Ethics in Medi-
cal Research inaugural lecture on November 6th.  
Approximately 100 people attended the captivat-
ing lecture by Dr. Ezekiel Emanuel, MD, PhD, and 
Chair of the Department of Bioethics at the Na-
tional Institutes of Health.  The presentation was 
the first annual lectureship sponsored through a 
donation by Dr. Steven J. Bander, a nephrologist 
in Chesterfield, Missouri.  Scheduled in partner-
ship with Saint Louis University (SLU), Dr. 
Emanuel also gave a lecture at SLU on Friday 
morning, the same day his brother, Rahm 
Emanuel, accepted the job of White House Chief 
of Staff to President-elect Barak Obama. 
Dr. Emanuel is an internationally known bio-
ethicist and breast oncologist. He has pub-
lished extensively on the ethics of clinical re-
search, advance care directives, end of life 
care issues, euthanasia, health care reform, 
the ethics of managed care, and the physician-
patient relationship. In addition to receiving 
numerous distinguished awards, he served on 
President Clinton’s Health Care Task Force, on 
the National Bioethics Advisory Commission 
(NBAC), and on the bioethics panel of the Pan-
American Healthcare Organization.  
Describing 4 categories of health care re-
form, Dr. Emanuel proceeded to build a case 
for his plan of guaranteed healthcare access.  
Using a value added tax, the plan would sup-
port a base level of portable health care for all 
Americans.   
Dr. Emanuel has also published multiple 
books, including his latest Healthcare, Guaran-
teed: A Simple, Secure Solution for America, in 
which he outlines his innovative approach to 
comprehensive healthcare system reform, an 
approach he developed together with Victor 
Fuchs, professor of Economics at Stanford 
University. 
For more information, see Dr. Emanuel’s 
slides posted on the Saint Louis University 
website at http://www.slu.edu/x16621.xml. 
titled ―MR Elastography: A New Quantitative Im-
aging Biomarker‖, Scarpellino Auditorium 
 
- December 15: Deadline for Letter of Intent for 
ICTS Bander Business Ethics in Medical Re-
search Funding Program 
- December 10: Initial deadline for ICTS Just-In-Time 
Core Usage grant applications.  Future deadlines 
are the 10th of each month or the first working day 
thereafter. 
 
- December 12 (9—10 am): Human Imaging Unit: 
Richard Ehman, MD, (Professor of Radiology, Mayo 
Clinic in Rochester, MN) will give a presentation 
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Research Funding Program proposals were 
due.  119 proposals were submitted. 
 
-November 24: Center for Clinical Research 
Ethics: Ana Iltis, PhD, Assistant Professor in the 
Department of Health Care Ethics at Saint 
Louis University presented a lecture entitled 
―Participants’ understanding of risks: Improving 
communication‖.  
 
-November 6: Inaugural ICTS Bander Lecture (see 
article above)   
 
-November 6: Human Imaging Unit: Dr. Juhani 
Knuuti, MD, PhD gave a presentation ―Multi-tracer 
and Multimodal Imaging Services for Pharma: Ex-
periences at Turku PET Centre‖ in the Scarpellino 
Auditorium, MIR Building.  
 
-November 17: BJHF/ICTS Clinical and Translational 
Investigators using 
ICTS Cores & Services 
to support their research 
should acknowledge the 
CTSA Grant 
UL1 RR024992 
Scholars and Trainees 
should acknowledge the 
appropriate CTSA 
Linked Grant 




statement is posted on 
the ICTS website. 
Dr. Ezekiel Emanuel and Dr. Stephen Bander  
Washington University School of Medicine 
Box 8066 
660 South Euclid Ave 
St. Louis, MO  63110-1010 
Ins t i tu te  of  Cl in ical  & 
T ra nsl a t ional  Sciences  
―What makes it 
so fun for me is 
that recruitment 
is so similar to 
marketing – 
knowing where 
the population of 
potential partici-
pants can be 
found and then 
making them 
aware of the tri-
als that are available.  Studies show that most 
people would volunteer for clinical research if 
they were just simply aware of it.‖  This proac-
tive, targeted approach was shown to be ex-
tremely effective in a pilot study the REC con-
ducted, doubling enrollment over a 12 month 
period (from 60% to 125%) in 2007 (see article 
November ICTS News, page 2). 
In his free time, Charles enjoys spending time 
with his wife Carly and 3 year old son, Aidan as 
well as activities like fly fishing, a skill he ac-
quired growing up in Alaska.  He enjoys staying 
active by playing basketball and working out.  If 
you pass by his office, you may hear him singing 
the praises of his Dallas Cowboys, since he con-
siders himself Missouri’s #1 Cowboys Fan.  
For more information about the Recruitment 
Enhancement Core or how the REC can help you 
and your study staff, contact Charles at         
rathmannc@wusm.wustl.edu or 314-362-0897. 
Clinical trials are impossible to execute with-
out participants.  Recruiting willing participants 
is one of the most challenging aspects of execut-
ing clinical research today.  Fortunately, the sole 
focus of the Washington University ICTS Recruit-
ment Enhancement Core (REC) is assisting in-
vestigators and coordinators in their clinical trial 
recruitment efforts.  Director Charles Rathmann 
is the innovative, energetic leader of this group 
of recruitment specialists. 
The REC provides a number of tools and tar-
geted approaches to develop individualized stra-
tegic recruitment plans.  One initiative is the 
Research Participant Registry, an upgrade of the 
successful Volunteer for Health program and 
database.  Establishing infrastructure to suc-
cessfully recruit study participants comes natu-
rally to Charles.  He spent 9 years in the pharma-
ceutical industry before coming to Washington 
University, gaining a strong portfolio of market-
ing and strategic planning experience with Pfizer 
Inc.  The opportunity to start a new Core that 
could make such a positive impact on so many 
people in the clinical research process was sim-
ply too intriguing to pass up. 
―As an institution, we owe it to the sponsors of 
the research that is conducted here to optimize 
recruitment and enrollment.  Not only does that 
focus allow us to continue to move this medical 
community forward but it allows our researchers 
to ask and answer the difficult, cutting edge 
questions that are the foundation of clinical 
research.‖ 
HAVE  YOU  M ET?  




Congratulations to our ICTS investigators with recent publications!  We thank you for citing the CTSA 
Grant Number (UL1 RR024992).  If you have used an ICTS resource, resulting publications must cite 
this grant number.  If your publication cites this grant and is not included in this list, please notify Jae 
Allen at jallen@dom.wustl.edu.  
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News, suggested articles or 
questions should be directed 
to ICTS@dom.wustl.edu or 
by contacting Jae Allen at 
314-362-9331. 
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